Dual antiplatelet therapy is safe and efficient after left atrial appendage closure.

@article{Maksym2018DualAT,
  title={Dual antiplatelet therapy is safe and efficient after left atrial appendage closure.},
  author={Jakub Maksym and Tomasz Mazurek and Janusz Kochman and Marek Grygier and Agnieszka Kapłon-Cieślicka and Michał Marchel and Piotr R Lodziński and Radosław Piątkowski and Radosław Wilimski and Paweł S Czub and Anna Fojt and Natalia Karolczak and Piotr Hendzel and Grzegorz Opolski},
  journal={Kardiologia polska},
  year={2018},
  volume={76 2},
  pages={
          459-463
        }
}
BACKGROUND Despite results of the PROTECT AF trial, many patients undergoing left atrial appendage closure (LAAC) have unconditional contraindications to warfarin. AIM We sought to investigate whether double antiplatelet therapy (DAPT) is safe in patients after LAAC. METHODS Forty-four consecutive patients (22 males, mean age 74 ± 7.8 years) with non… CONTINUE READING